Zoetis releases Draxxin 25 for BRD treatment in small calves

Zoetis releases Draxxin 25 for BRD treatment in small calves

Zoetis' Draxxin 25 offers lower concentration of tulathromycin to treat BRD in new calves

Zoetis on Wednesday announced the launch of Draxxin 25 Injectable Solution, a lower concentration of Draxxin tulathromycin Injectable Solution, to treat bovine respiratory disease in suckling, dairy and veal calves.

Just like the current concentration of Draxxin, Draxxin 25 offers broad-spectrum coverage against the major causes of BRD, including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis, Zoetis says.

However, producers and veterinarians should note that Draxxin 25 has a pre-slaughter withdrawal time of 22 days, compared with the 18-day pre-slaughter time for Draxxin.

Zoetis' Draxxin 25 offers lower concentration of tulathromycin to treat BRD in new calves

"The efficacy of Draxxin has made it a leading choice by veterinarians and producers for the treatment of BRD in larger, ruminating calves," said Dr. Robert Lynch, senior veterinarian, Dairy Technical Services, Zoetis. "The new formulation of Draxxin 25 allows for more-accurate and convenient dosing for smaller calves. Producers and veterinarians can be confident they are administering the correct treatment needed."

When administered according to the label, Draxxin is absorbed and distributed quickly to provide effective, single-dose therapy for BRD, Zoetis says.

Draxxin 25 is available in 100 mL and 250 mL vials and may be purchased through a veterinarian or animal health retailer with a veterinarian's prescription.

Zoetis also announced the approval of Draxxin for the treatment against the major causes of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis in suckling, dairy and veal calves. Previously, Draxxin was approved only for use in nonlactating dairy cattle (cattle younger than 20 months of age, including dairy calves) and beef cattle.

"Through Zoetis' efforts to obtain FDA approval to remove the veal calf restriction and include suckling calves in the Draxxin label, veterinarians can prescribe Draxxin with confidence and producers can practice responsible antibiotic use while treating BRD symptoms with a demonstrated and effective BRD treatment option for veal calves," Lynch said.

Learn more about Draxxin 25 on the Zoetis Draxxin website.

TAGS: Regulatory
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish